Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Not for All Patients Contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
TB-500 promotes angiogenesis (new blood vessel formation), which raises theoretical concerns for individuals with cancer history or risk factors
TB-500 (Thymosin Beta-4 analogue) operates through actin binding and cell migration pathways with stronger evidence in muscle, cardiac, and skin repair models
When I went after BPC-157, I was talking about a specific molecule, sold through gray market suppliers and unregulated compounding pharmacies, that people are injecting subcutaneously into their muscle tissue, into their joints based on animal data from a single research group in Zagreb
&srotate=0)
:max_bytes(150000):strip_icc()/VWH-GettyImages-1163357870-742f280318c14dec90d89584573e7f67.jpg)
